The global mental illness drugs market is anticipated to grow at a significant CAGR during the forecast period (2024-2031). The major factors that are expected to accelerate the growth of the market include the rise in the prevalence of mental health disorders, such as schizophrenia and bipolar disorder among the population. According to the Anxiety and Depression Association of America, Anxiety disorders are the most common mental illness in the US, affecting 40 million adults in the US aged 18 and older, or 18.1% of the population every year. Nearly one-half of those diagnosed with depression are also diagnosed with an anxiety disorder. The World Health Organization (WHO) has recommended mental health action plan to promote mental health and prevent mental disorders in the member states. Moreover, according to the key facts published by the WHO, an estimated 300 million people are affected by depression, and 60 million people are affected by bipolar disorder, globally. 

Get Free Sample link @ https://www.omrglobal.com/request-sample/mental-illness-drugs-market

Anxiety disorders are the most common psychiatric illnesses affecting children and adults. It is evaluated that 44 million American grown-ups experience the ill effects of uneasiness. Merely, about one-third of those suffering from an anxiety disorder receive treatment, even though the disorders are highly treatable. Therefore, the rising prevalence of mental disorders is contributing to the growth of the market. Schizophrenia is a serious mental disorder and is affecting a large number of people across the globe. The disease is mainly characterized by distortions in thinking, emotions, and sense of self and behavior. World Health Organization has stated that around 23 million people across the globe are affected by this disorder among which 12 million are male and 9 million are females. National Institute of Mental Health has stated that the prevalence of Schizophrenia and related symptoms is around 0.25% and 0.64% and this is increasing rapidly. This rise in the prevalence of the disease is contributing to market growth during the forecast period.

Full report of Mental Illness Drugs Market available @ https://www.omrglobal.com/industry-reports/mental-illness-drugs-market

Market Coverage

Segment Covered- 

o             By Product Type 

o             By Application 

Regions covered-

o             North America

o             Europe

o             Asia-Pacific

o             Rest of the World

Competitive Landscape: Eli Lily and Company, AstraZeneca plc, GlaxoSmithKline plc, and Pfizer Inc., among others. 

Key questions addressed by the report

What is the market growth rate?
Which segment and region dominate the market in the base year?
Which segment and region will project the fastest growth in the market?
How has COVID-19 impacted the market?

o             Deviation from the pre-COVID-19 forecast

o             Most affected region and segment

Who is the leader in the market?
How are players addressing challenges to sustain growth?
Where is the investment opportunity?

Global Mental Illness Drugs Market Report by Segment

By Product Type

Antipsychotics
Antidepressants
Anxiolytics
Anti-Seizure
Stimulants

By Application

Hospitals
Clinics
Drug Stores

Reasons to Buying From us -

1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.




For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/mental-illness-drugs-market








Media Contact:

Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +91 780-304-0404
Company Name: Orion Market Research

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.